DDInter1836 DDInter832
Torasemide is a high-ceiling loop diuretic. Structurally, it is a pyridine-sulfonylurea used as an antihypertensive agent. Torasemide was first approved for clinical use by the FDA in 1993.
A trihydroxy sugar alcohol that is an intermediate in carbohydrate and lipid metabolism.
Torasemide {u} (Compound) treats {v} (Disease) hypertension
Torasemide {u} (Compound) binds {v} (Gene) CYP2C9
Torasemide {u} (Compound) upregulates {v} (Gene) PAK1
Torasemide {u} (Compound) palliates {v} (Disease) chronic kidney failure
Torasemide {u} (Compound) is included by {v} (Pharmacologic Class) Increased Diuresis at Loop of Henle
Torasemide {u} (Compound) downregulates {v} (Gene) ADI1
Torasemide {u} (Compound) causes {v} (Side Effect) Oropharyngeal discomfort
Torasemide {u} may cause a minor interaction that can limit clinical effects when taken with {v} Oxytetracycline
Torasemide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Diphenhydramine
Torasemide {u} may cause a moderate interaction that could exacerbate diseases when taken with {v} Insulin lispro
Torasemide (Compound) treats hypertension (Disease)
Torasemide (Compound) binds CYP2C9 (Gene)
Torasemide (Compound) upregulates PAK1 (Gene)
Torasemide (Compound) palliates chronic kidney failure (Disease)
Torasemide (Compound) is included by Increased Diuresis at Loop of Henle (Pharmacologic Class)
Torasemide (Compound) downregulates ADI1 (Gene)
Torasemide (Compound) causes Oropharyngeal discomfort (Side Effect)
Torasemide may cause a minor interaction that can limit clinical effects when taken with Oxytetracycline
Torasemide may cause a moderate interaction that could exacerbate diseases when taken with Diphenhydramine
Torasemide may cause a moderate interaction that could exacerbate diseases when taken with Insulin lispro